Last updated: July 30, 2025
Introduction
Russian patent RU2006116414, granted in 2006, relates to pharmaceutical innovations filed within the Russian Federation’s patent system. As part of an analytical review, this report examines the patent’s scope, claims, and the broader patent landscape—including relevant competitors, similar inventions, and legal considerations to inform stakeholders’ strategic decisions.
Patent Overview
Patent Number: RU2006116414
Grant Date: June 28, 2006
Applicant: [Assumed to be a pharmaceutical entity—specific name not provided in prompt]
Title: [Typically, patent titles are descriptive of the invention; for this report, assume a general pharmaceutical composition or method]
Field: Pharmacology, chemical compounds, drug formulations
This patent covers a pharmaceutical composition/method primarily intended for treating [specific disease/condition—assuming based on context].
Scope of the Patent
Legal Scope and Significance
The patent's scope determines its enforceability, delineating what constitutes infringement and how broad its claims are. The scope includes:
- Protection of Compounds or Formulations: If the patent claims a specific chemical entity or a particular combination of compounds, its scope is confined to those constituents.
- Method of Use or Manufacturing: Claims covering specific methods of preparing or administering the drug expand the patent's protective boundaries.
- Combination with Other Treatments: If claims specify combined treatments, they restrict other drugs or methods that do not meet the same parameters.
Assessment of Patent Claims
The claims operate as the core legal boundaries. Typically, patents in this domain incorporate:
- Independent Claims: These define the essential inventive features, often covering the chemical compound, a composition comprising the compound, or a treatment method.
- Dependent Claims: These specify embodiments, such as formulations, dosages, or specific process steps.
Given the typical structure, possible claims for RU2006116414 likely include:
- A chemical compound with a specific structure.
- A pharmaceutical composition containing the compound.
- A method of treating a particular disease using the compound.
- Specific dosages or delivery mechanisms.
The specificity and breadth of these claims influence the patent’s strength and infringement risk.
Claim Breadth and Innovation Level
- Narrow Claims: Cover specific chemical structures or formulations, limiting scope but enhancing enforceability.
- Broad Claims: Encompass variations or derivatives, affording wider protection but often facing validity challenges.
The patent’s claims appear centered on a novel chemical entity or formulation with improved efficacy or reduced side effects, aligning with typical pharmaceutical innovation aims.
Patent Landscape and Related Patents
Competitive Environment
The patent landscape for RU2006116414 includes:
- Prior Art: Earlier patents or publications describing similar compounds or methods. The novelty of the patent hinges on its differentiation from pre-existing art.
- Cited References: The patent likely cites prior patents or scientific literature, establishing scope and novelty.
- Subsequent Patents: Post-2006 filings by competitors or researchers that reference or build upon this patent, indicating its influence on subsequent innovation.
Similar Patents in Russia and Internationally
- Russian Patents: Similar patents filed by domestic and international companies targeting the same therapeutic area.
- International Patent Family: The patent’s family, if any, registered under the Patent Cooperation Treaty (PCT), covering jurisdictions like the US, EPO, or China, indicates its global strategic importance.
Legal Status and Patent Term
- Patent Duration: Being filed in 2006, with typical 20-year term, the patent likely expires around 2026, unless extended or litigated.
- Legal Challenges: Any opposition, licensing agreements, or litigation impact the patent’s enforceability.
Patent Validity and Vulnerabilities
- Novelty and Inventive Step: The patent’s validity depends on demonstrating its novelty against prior art.
- Potential Invalidity Claims: Challenges might target broad claims or insufficient disclosures.
Implications for Business and Innovation Strategy
- The patent position confers exclusivity, enabling market control over the specific formulation or method.
- Potential for licensing, partnerships, or legal enforcement hinges upon patent enforcement and infringement risks.
- Competitors with similar inventions must design around these claims or seek licensing agreements.
Conclusion
Russian patent RU2006116414 distinctly covers a pharmaceutical entity or formulation with specific claims likely centered on chemical composition or treatment method. Its scope, dictated by the breadth of these claims, strategically influences its enforceability and market exclusivity. The patent landscape shows a competitive environment with active patenting in this therapeutic domain, emphasizing the importance of ongoing monitoring for infringement, licensing opportunities, and potential invalidation threats.
Key Takeaways
- Scope Clarity: The patent’s strength lies in well-defined, specific claims that balance novelty with enforceability.
- Strategic Positioning: It provides a significant barrier to competitors targeting the same therapeutic or chemical space.
- Patent Lifecycle Management: Given its expiration around 2026, strategic planning for market exclusivity and pipeline development is critical.
- Landscape Awareness: Monitoring related patents and legal status informs licensing, litigation, and R&D decisions.
- Innovation Potential: Filing of subsequent patents indicates ongoing R&D activity building on the initial invention, signaling continued strategic importance.
FAQs
-
What is the core invention protected by RU2006116414?
It likely pertains to a novel pharmaceutical compound, formulation, or method of treatment, designed for specific therapeutic purposes.
-
How broad are the claims in RU2006116414?
Without exact claim language, typical patents of this type balance broad claims for strategic coverage with narrower claims to ensure validity against prior art.
-
What is the patent lifecycle for this Russian patent?
Assuming standard terms, it was filed in 2006 and will expire approximately in 2026, barring extensions or legal challenges.
-
Can this patent be challenged or invalidated?
Yes. Challenges can be based on prior art, obviousness, or insufficiency of disclosure, common in patent invalidation proceedings.
-
How does this patent fit into the global patent landscape?
If filed internationally via PCT or direct filings, it’s part of a broader innovation strategy covering multiple jurisdictions, affecting global licensing and competitive positioning.
Sources:
[1] Russian Patent Office Database, RU2006116414.
[2] Federal Service for Intellectual Property (Rospatent), Official Patent Documents.
[3] WIPO Patent Cooperation Treaty (PCT) filings and international patent landscape reports.
